 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/19/2024 |
$15.60 |
$16.15 |
$15.43 |
$15.60 |
477.10K | | 04/22/2024 |
$15.60 |
$15.66 |
$13.88 |
$14.23 |
287.30K | | 04/23/2024 |
$14.35 |
$15.76 |
$14.12 |
$15.50 |
443.80K | | 04/24/2024 |
$15.59 |
$16.25 |
$15.24 |
$16.22 |
441.60K | | 04/25/2024 |
$16.05 |
$17.02 |
$15.74 |
$16.87 |
509.30K |
|
|
| ALX Oncology Holdings is a holding company. Through its subsidiaries, Co. is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on capabilities in protein engineering and oncology led by the CD47 blocker, evorpacept. Co.'s primary product candidate, evorpacept, is a CD47 blocking biologic in development as a combination therapy with other anti-cancer agents for treatment of various oncology indications, including myelodysplastic syndromes, acute myeloid leukemia, head and neck squamous cell carcinoma, gastric/gastroesophageal junction and breast cancer. | |
|
ALX Oncology Holdings (ALXO) has the following price history information. Looking back at ALXO historical stock prices for the last five trading days, on April 19, 2024, ALXO opened at $15.60, traded as high as $16.15 and as low as $15.43, and closed at $15.60. Trading volume was a total of 477.10K shares. On April 22, 2024, ALXO opened at $15.60, traded as high as $15.66 and as low as $13.88, and closed at $14.23. Trading volume was a total of 287.30K shares. On April 23, 2024, ALXO opened at $14.35, traded as high as $15.76 and as low as $14.12, and closed at $15.50. Trading volume was a total of 443.80K shares. On April 24, 2024, ALXO opened at $15.59, traded as high as $16.25 and as low as $15.24, and closed at $16.22. Trading volume was a total of 441.60K shares. On April 25, 2024, ALXO opened at $16.05, traded as high as $17.02 and as low as $15.74, and closed at $16.87. Trading volume was a total of 509.30K shares.
ALXO Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into ALX Oncology Holdings shares, starting with a $10,000 purchase of ALXO, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
07/20/2020 |
|
| End date: |
04/25/2024 |
|
| Start price/share: |
$30.33 |
|
| End price/share: |
$16.87 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-44.38% |
|
| Average Annual Total Return: |
-14.42% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$5,562.09 |
|
| Years: |
3.77 |
|
|
|
| Date |
Close |
| 04/19/2024 | $15.60 | | 04/22/2024 | $14.23 | | 04/23/2024 | $15.50 | | 04/24/2024 | $16.22 | | 04/25/2024 | $16.87 |
|
|
Free ALXO Email Alerts:
